Working towards better health for all in Europe.
The need for strong European action to tackle the flaws in our health systems and support our health workforce have been highlighted by different countries’ ability to respond to the COVID-19 outbreak as effectively as others.
A fair and equitable allocation of safe and effective COVID-19 vaccines contributes to social and health equity, is an opportunity to reduce long standing social disparities in Europe, and will protect everyone’s health.
Antimicrobial resistance (AMR)
AMR is threatening human and animal health as well as the environment. The consequences of inaction are too grave to contemplate.
Digital health has the power to revolutionise healthcare and tackle health inequalities – done wrong, it could exacerbate social and gender equity issues.
Food Systems & NCD Prevention
Transforming the food system and preventing non-communicable diseases (NCDs) for human well-being and planetary health.
Health inequalities and Roma health
Stand against discrimination, for inclusion and equal opportunities for all to live, work and age in sustainable, healthy environments.
Trade for health
Trade for health, not health for trade! A progressive trade policy that works for the public good is possible and achievable.
Universal access and affordable medicines
We stand for transparency, accountability and the public interest in pharmaceuticals – and better access to better medicines for all.
Digital transformation in health and care: the point of view of the European Society for Organ Transplantation
Artificial Intelligence and machine learning will play a vital role in managing organ transplant patients.
The power of youth in the digital health transition
For effective and trustworthy digital innovations patients should be involved in the creation and decision-making process.
Diabetes showcases the promises of digital health for chronic diseases and unfolds the full potential of data.
European Health Data Space an opportunity for the public health community to make their voices heard.
AI-based decision-making, prospects, and risks for health in relation to the 2020 White Paper on Artificial Intelligence.
EPHA #A2MDialogues: The Oslo Medicines Initiative: a new social contract with pharma
15 June 2021 | 13:00-14:00 CEST